Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic Candidates
January 16, 2017 10:51 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta , Jan. 16, 2017 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. announced they have received non-refundable financial contribution from the National Research Council of Canada’s...
Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
November 30, 2015 10:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that it was named "Company of the Year" by BioAlberta during the Association's 16th Annual General...
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
November 09, 2015 16:43 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada, announced their receipt of the 2015 Outstanding...
Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
September 12, 2013 13:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented
results of preclinical studies demonstrating that FPI-1465 increases
the activity of...
Fedora Pharmaceuticals Unveils Details of Antibiotic Resistance Program in 10 Posters at 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
August 27, 2013 08:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that the Company
and its collaborators will be presenting 10 posters at the upcoming
Interscience...
Fedora Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Newly Created Board of Directors
October 31, 2012 08:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Oct. 31, 2012 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced the creation of a
Board of
Directors and appointment of Leonard E. Post, Ph.D. and Ronald
W. Odynski,...
Fedora Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer
September 05, 2012 10:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 5, 2012 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced the appointment of
Thomas Parr,
Ph.D. to the newly created role of chief scientific officer.
Dr. Parr...